Clinical Trial Update: Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of leflunomide, pomalidomide, and dexamethasone for relapsed or refractory multiple myeloma is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Leflunomide (Leflunomide)
• Pomalyst (pomalidomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 2 | Status: RECRUITING